Masoudi Frederick A, Plomondon Mary E, Magid David J, Sales Anne, Rumsfeld John S
Department of Medicine, Denver Health Medical Center, Denver, CO 80204, USA.
Am Heart J. 2004 Apr;147(4):623-9. doi: 10.1016/j.ahj.2003.12.010.
Although there is accumulating evidence that renal insufficiency is an independent risk factor for mortality after acute myocardial infarction (AMI), it is not known whether renal dysfunction is associated with an increased mortality rate after a broad range of acute coronary syndromes, including unstable angina.
We examined consecutive patients from 24 Veterans Affairs hospitals with confirmed AMI or unstable angina between March 1998 and February 1999, who were categorized into groups according to estimated glomerular filtration rate (GFR). Multivariable regression was used to assess the independent association between GFR and the 7-month mortality rate, adjusting for differences in patient characteristics and treatment.
Of the 2706 patients, 436 (16%) had normal renal function (GFR >90 mL/min/1.73 m(2)), 1169 (43%) had mild renal insufficiency (GFR 60-89 mL/min/1.73 m(2)), 864 (32%) had moderate renal insufficiency (GFR 30-59 mL/min/1.73 m(2)), and 237 (9%) had severe renal insufficiency (GFR <30 mL/min/1.73 m(2)). Patients with renal insufficiency were less likely to undergo coronary angiography or to receive aspirin or beta-blockers at discharge. In multivariable models, renal insufficiency was associated with a higher odds of death (mild renal insufficiency: odds ratio [OR] = 1.76; 95% CI, 0.93-3.33; moderate renal insufficiency: OR = 2.72; 95% CI, 1.43-5.15; and severe renal insufficiency: OR = 6.18; 95% CI, 3.09-12.36; all compared with normal renal function). The associations between renal insufficiency and mortality rate were similar in both the AMI and unstable angina subgroups (P value for interaction =.45).
Renal insufficiency is common and is associated with higher risks for death in patients with a broad range of ACS at presentation. Future efforts should be dedicated to determining whether more aggressive treatment will optimize outcomes in this patient population.
尽管越来越多的证据表明肾功能不全是急性心肌梗死(AMI)后死亡的独立危险因素,但尚不清楚肾功能障碍是否与包括不稳定型心绞痛在内的广泛急性冠状动脉综合征后的死亡率增加有关。
我们研究了1998年3月至1999年2月期间来自24家退伍军人事务医院的连续确诊为AMI或不稳定型心绞痛的患者,这些患者根据估计的肾小球滤过率(GFR)进行分组。采用多变量回归评估GFR与7个月死亡率之间的独立关联,并对患者特征和治疗差异进行校正。
在2706例患者中,436例(16%)肾功能正常(GFR>90 mL/min/1.73 m²),1169例(43%)有轻度肾功能不全(GFR 60 - 89 mL/min/1.73 m²),864例(32%)有中度肾功能不全(GFR 30 - 59 mL/min/1.73 m²),237例(9%)有重度肾功能不全(GFR<30 mL/min/1.73 m²)。肾功能不全的患者出院时接受冠状动脉造影、阿司匹林或β受体阻滞剂治疗的可能性较小。在多变量模型中,肾功能不全与死亡几率较高相关(轻度肾功能不全:比值比[OR]=1.76;95%可信区间,0.93 - 3.33;中度肾功能不全:OR = 2.72;95%可信区间,1.43 - 5.15;重度肾功能不全:OR = 6.18;95%可信区间,3.09 - 12.36;均与正常肾功能相比)。在AMI和不稳定型心绞痛亚组中,肾功能不全与死亡率之间的关联相似(交互作用P值=0.45)。
肾功能不全在就诊时患有广泛急性冠状动脉综合征(ACS)的患者中很常见,且与较高的死亡风险相关。未来的努力应致力于确定更积极的治疗是否能优化该患者群体的预后。